Literature DB >> 7811753

Certain properties of isoniazid inhibition of mycolic acid synthesis in cell-free systems of M. aurum and M. avium.

A Quémard1, S Mazères, A Sut, G Lanéelle, C Lacave.   

Abstract

In Mycobacterium tuberculosis isoniazid (INH)-susceptibility and the presence of a thermolabile catalase-peroxidase (T-catalase) are nearly always associated. It is shown in this study that an INH-susceptible strain of M. aurum had a T-catalase activity while its resistant mutants did not, but an in vitro susceptible strain of M. avium had a strong catalase activity without any detectable peroxidase properties. Synthesis of mycolic acids is a genus-specific target for INH and there is an excellent parallelism between INH-susceptibility of intact cells and that of a cell-free system synthesizing mycolic acids. We investigated whether the INH-inhibition of mycolic acid cell-free synthesis was dependent on a T-catalase activity in M. aurum and M. avium: no catalase activity was detectable in any of the cell-free systems tested, and addition of T-catalase from susceptible M. aurum strain to an INH-resistant system did not render it sensitive. So INH can inhibit mycolic acid synthesis independently of the presence of a T-catalase. An INH-susceptible cell-free system prepared from INH-treated (at the MIC) cells was progressively and irreversibly inhibited, while incubation of the same susceptible system in the presence of INH did not result in a significant irreversible inhibition. The possible participation of T-catalase in the irreversible effect of INH is discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7811753     DOI: 10.1016/0005-2760(94)00174-w

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Effects of isoniazid on ultrastructure of Mycobacterium aurum and Mycobacterium tuberculosis and on production of secreted proteins.

Authors:  F Bardou; A Quémard; M A Dupont; C Horn; G Marchal; M Daffé
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

2.  Antimycobacterial action of thiolactomycin: an inhibitor of fatty acid and mycolic acid synthesis.

Authors:  R A Slayden; R E Lee; J W Armour; A M Cooper; I M Orme; P J Brennan; G S Besra
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

3.  Determination of the primary target for isoniazid in mycobacterial mycolic acid biosynthesis with Mycobacterium aurum A+.

Authors:  P R Wheeler; P M Anderson
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

4.  Identification of Prognostic Immune-Related Genes by Integrating mRNA Expression and Methylation in Lung Adenocarcinoma.

Authors:  Jie Zhu; Min Wang; Daixing Hu
Journal:  Int J Genomics       Date:  2020-07-09       Impact factor: 2.326

5.  Transfer of the first arabinofuranose residue to galactan is essential for Mycobacterium smegmatis viability.

Authors:  Libin Shi; Roukun Zhou; Zhentong Liu; Todd L Lowary; Peter H Seeberger; Bridget L Stocker; Dean C Crick; Kay-Hooi Khoo; Delphi Chatterjee
Journal:  J Bacteriol       Date:  2008-06-13       Impact factor: 3.490

6.  InhA, the enoyl-thioester reductase from Mycobacterium tuberculosis forms a covalent adduct during catalysis.

Authors:  Bastian Vögeli; Raoul G Rosenthal; Gabriele M M Stoffel; Tristan Wagner; Patrick Kiefer; Niña Socorro Cortina; Seigo Shima; Tobias J Erb
Journal:  J Biol Chem       Date:  2018-09-14       Impact factor: 5.157

7.  Dissecting the mycobacterial cell envelope and defining the composition of the native mycomembrane.

Authors:  Laura Chiaradia; Cyril Lefebvre; Julien Parra; Julien Marcoux; Odile Burlet-Schiltz; Gilles Etienne; Maryelle Tropis; Mamadou Daffé
Journal:  Sci Rep       Date:  2017-10-09       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.